Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.

AUTOR(ES)

Qin, X Q

RESUMO

E2F-1 is a transcription factor suspected of activating genes required for S phase and a known target for the action of RB, the retinoblastoma gene product. Its induction in quiescent fibroblasts led to S-phase entry followed by apoptosis. E2F-1-mediated apoptosis was suppressed by coexpression of wild-type RB or a transdominant negative mutant species of p53. In contrast, coexpression of a naturally occurring loss-of-function RB mutant or wild-type p53 did not suppress the induction of apoptosis under these conditions. Thus, deregulated E2F-1 activity gives rise to proliferative and apoptotic signals. p53 appears to participate in the execution of the latter.

Documentos Relacionados

• Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis.
• Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis.
• Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis.
• Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression.
• p53 and E2F-1 cooperate to mediate apoptosis.